Friday, February 10, 2012

Schizophrenia Home>
News>
Clinical Trial: Study of a New Drug for Schizophrenia

Save to My Home

This helped!

Introducing Mood 24/7, a new tool that helps you track your mood from day to day using your mobile phone. Try it today!

Clinical Trial: Study of a New Drug for Schizophrenia

(National Institutes of Health) UPDATED 2010-07-01

This is a study to assess the safety and tolerability of multiple doses of a new drug called AQW051 in people with schizophrenia. This national study is currently recruiting adults ages 18 years to 60 years who have been diagnosed with schizophrenia and who meet the study's other criteria. Read full story >

See all Schizophrenia News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Clinical Trial: Study of a New Drug for Schizophrenia

People who read this also read...

What the community is saying...

Schizophrenia Early Warning Signs

Christina Bruni